United States · Who invested in GeneVentiv Therapeutics?
GeneVentiv Therapeutics's investors include National Heart, Lung and Blood Institute.
United States · Funded startup
Who invested in GeneVentiv Therapeutics
Funding summaryUpdated 26 Oct 2026
$2.5Mraised across 1 round since 2024, from 1 source
- Latest round
- Grant, $2.5MApr 2024
- Investors
- 1
The rounds
- Apr 2024
Founders and team
From the SEC filings it signed: 1 on the team.
- Damon RaceExecutive Officer, Directori
On the board, as filediRichard Limehouse
Quick answers about GeneVentiv Therapeutics
How much has GeneVentiv Therapeutics raised?
GeneVentiv Therapeutics has raised $2.5M across 1 round since 2024.
When did GeneVentiv Therapeutics last raise?
GeneVentiv Therapeutics's most recent round was a Grant of $2.5M in Apr 2024.
What was GeneVentiv Therapeutics's biggest round?
Its most recent round, $2.5M in Apr 2024, is also its largest on record.
Who backed GeneVentiv Therapeutics first?
GeneVentiv Therapeutics's first round on record, in Apr 2024, was backed by National Heart, Lung and Blood Institute.
What stage is GeneVentiv Therapeutics at?
GeneVentiv Therapeutics's latest named round is a Grant, in Apr 2024.
Where is GeneVentiv Therapeutics based?
GeneVentiv Therapeutics is based in the United States.
Companies like GeneVentiv Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.